Eloxx Pharmaceuticals Inc: Guggenheim cuts target price to $40 from $43
ELOX•Guggenheim cut its target price for Eloxx Pharmaceuticals to $40 from $43.
Related News
Expand Energy Corporation: Gerdes Energy Research raises target price by $2 to $147
EXE•
Principal Financial Group Inc: Piper Sandler cuts target price to $125 from $128
PFG•
Esquire Financial Holdings price target raised to $143 from $137
ESQ•
Japan's Nikkei jumps as tech results revive AI optimism
EWJ•
BofA Global Research raises SoFi Technologies price objective to $16.50 from $16
SOFI•